Cilostazol may be a better therapeutic agent for acute ischemic stroke because of its efficacy in preventing post-stroke depression

Yuling Zhang, Ganggang Yang, Rui Wang, Xin Wang, Xiying Tan, Chaozhi Tang
doi: https://doi.org/10.1101/2023.10.30.23297771

Article Information

doi 
https://doi.org/10.1101/2023.10.30.23297771
History 
  • October 31, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Yuling Zhang1,
  2. Ganggang Yang1,
  3. Rui Wang2,
  4. Xin Wang2,
  5. Xiying Tan2 and
  6. Chaozhi Tang1,2,✉
  1. 1Xinxiang Key Laboratory of Targeted Drugs and Neuromodulation, College of Life Sciences, Henan Normal University, Xinxiang 453007, China
  2. 2Department of Neurology, Xinxiang First People’s Hospital, Xinxiang 453100, China
  1. ↵✉Correspondence: tcz800808{at}126.com
Back to top
Posted October 31, 2023.
Download PDF
Data/Code
Email
Cilostazol may be a better therapeutic agent for acute ischemic stroke because of its efficacy in preventing post-stroke depression
Yuling Zhang, Ganggang Yang, Rui Wang, Xin Wang, Xiying Tan, Chaozhi Tang
medRxiv 2023.10.30.23297771; doi: https://doi.org/10.1101/2023.10.30.23297771
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area